Meanwhile, NLG919‐S‐S‐PPa heterodimer can be cleaved under endogenous GSH conditions to release NLG919 for inactivating IDO‐1 as well as the immunosuppressive Tregs in the tumor microenvironment. Here, IDO1 is linked to neoplasm.